Revolution Medicines, Inc. (RVMD)
NASDAQ: RVMD · Real-Time Price · USD
132.82
-2.48 (-1.83%)
Apr 27, 2026, 2:59 PM EDT - Market open
Revolution Medicines Market Cap
Revolution Medicines has a market cap or net worth of $27.93 billion as of April 27, 2026. Its market cap has increased by 327.84% in one year.
Market Cap
27.93B
Enterprise Value
26.38B
1-Year Change
327.84%
Ranking
Category
Stock Price
$132.82
Market Cap Chart
Since February 13, 2020, Revolution Medicines's market cap has increased from $1.64B to $27.93B, an increase of 1,598.71%. That is a compound annual growth rate of 57.94%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 24, 2026 | 28.46B | 84.81% |
| Dec 31, 2025 | 15.40B | 90.50% |
| Dec 31, 2024 | 8.08B | 71.26% |
| Dec 29, 2023 | 4.72B | 123.15% |
| Dec 30, 2022 | 2.11B | 14.03% |
| Dec 31, 2021 | 1.85B | -29.43% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Feb 13, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| argenx SE | 48.50B |
| Alnylam Pharmaceuticals | 40.52B |
| BeOne Medicines AG | 33.36B |
| Royalty Pharma | 29.27B |
| Insmed | 29.18B |
| BioNTech SE | 26.67B |
| Moderna | 20.12B |
| Roivant Sciences | 19.62B |